Adragos Hub

Selecting a Contract Development and Manufacturing Organisation for small molecule formulation and High-Potency Active Pharmaceutical Ingredient handling is one of the most consequential decisions a pharma or biotech team will make. Choosing the right small molecule HPAPI CDMO shortens timelines, […]

Scaling semi-solid and liquid pharmaceutical products from development batches to commercial volumes requires a disciplined sequence of technology transfer, equipment qualification and process validation activities. For creams, ointments, gels, suspensions, solutions and syrups, the rheological behaviour, homogeneity and microbiological control […]

Scaling Semisolids & Liquids in Pharma | Adragos Scaling semisolid and liquid pharmaceutical products from laboratory to commercial manufacturing requires a systematic progression through formulation development, pilot batch production, process validation and technology transfer. Each stage introduces new critical process […]

Process validation is what turns a promising semi-solid or liquid formulation into a product that can be made reliably at commercial scale. This guide explains what process validation in pharma scale-up is, the three regulatory stages it follows, why scale-up […]

A value added medicine offers a practical route to a differentiated specialty product without the cost and risk of developing a new molecule. This guide explains what a value added medicine in specialty pharma is, why these products matter, the […]

Pharmaceutical scale-up for semi-solid and liquid products is the structured transfer of a formulation from laboratory or pilot scale to commercial manufacturing batches. The process requires alignment between formulation behaviour, equipment geometry, process parameters and quality controls, so that the […]